ArticleJournal of the American Academy of Dermatology2012
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.
Article in Journal of the American Academy of Dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Dysplastic Nevi and Superficial Borderline Atypical Melanocytic Lesions: Description of an Algorithmic Clinico-Pathological Classification.Dermatopathology (Basel, Switzerland) · 2025Review
- Review
- Advances in melanoma: epidemiology, diagnosis, and prognosis.Frontiers in medicine · 2023Review
- Targeting the ERK Signaling Pathway in Melanoma.International journal of molecular sciences · 2019Review
- Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy.British journal of cancer · 2018Article
- Review
- Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation.Translational oncology · 2016Article
- Article
- In vivo assessment of optical properties of melanocytic skin lesions and differentiation of melanoma from non-malignant lesions by high-definition optical coherence tomography.Archives of dermatological research · 2016Article
- [Dysplastic melanocytic nevus].Der Pathologe · 2015Review
- A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma.BMC cancer · 2014Article
- Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.Virchows Archiv : an international journal of pathology · 2014Article
- The so-called dysplastic nevus is not dysplastic at all.Dermatology practical & conceptual · 2013Article
- Article
- Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression.Tzu chi medical journalReview
- The "Dysplastic Nevus" Conundrum: A Look Back, a Peek Forward.Dermatopathology (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The dysplastic nevus is a discreet histologic entity that exhibits some clinical and histologic features overlapping with common nevi and melanoma. These overlapping features present a therapeutic challenge, and with a lack of accepted guidelines, the management of dysplastic nevi remains a controversial subject. Although some differences between dysplastic and common nevi can be detected at the molecular level, there are currently no established markers to predict biologic behavior. In part II of this continuing medical education article, we will review the molecular aspects of dysplastic nevi and their therapeutic implications. Our goal is to provide the clinician with an up-to-date understanding of this entity to facilitate clinical management of patients with nevi that have histologic dysplasia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.